Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Takeda and Protagonist Therapeutics have jointly submitted a new drug application (NDA) seeking approval from the US Food and ...

Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

The evidence indicates that non-invasive monitoring (near-infrared spectroscopy; NIRS) of oxygen in brain tissue likely does not reduce death rates or short-term brain problems for very premature ...

Objective To perform a large-scale pairwise and network meta-analysis on the effects of all relevant exercise training modes on resting blood pressure to establish optimal antihypertensive exercise ...